Prof. Dr. Cornelia Ulrich

The newly established Division of Preventive Oncology at the German Cancer Research Center is involved in studies of genetic susceptibility and cancer etiology and prognosis. Gene-environment interactions with nutritional factors and medications are a key emphasis, with the goal to enable tailoring of prevention strategies and treatments (“personalized medicine”). Scientists of the Division investigate primary and secondary prevention of cancer; one major emphasis are studies on exercise and cancer. New methods for early detection and screening are explored and evaluated. Finally, an important goal of the Division is the identification of health behaviors that will help cancer patients to improve their prognosis and well-being.

Among other research studies, Professor Ulrich leads the interdisciplinary ColoCare Study in Heidelberg as part of an international consortium with the Fred Hutchinson Cancer Research Center in Seattle and the Moffitt Cancer Center in Tampa. The study builds on a cohort of colorectal cancer patients and has as its main aim the improvement of prognosis among colorectal cancer patients through modifiable health behaviors as well as molecularly tailored therapies.

COS-Profile of Prof. Cornelia Ulrich